Advantage Trust Company’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $639K | Sell |
5,052
-86
| -2% | -$10.9K | 0.31% | 27 |
|
2025
Q1 | $657K | Sell |
5,138
-4,220
| -45% | -$540K | 0.4% | 23 |
|
2024
Q4 | $1.24M | Sell |
9,358
-4,344
| -32% | -$574K | 0.73% | 15 |
|
2024
Q3 | $2M | Buy |
13,702
+63
| +0.5% | +$9.17K | 1.35% | 15 |
|
2024
Q2 | $1.87M | Sell |
13,639
-270
| -2% | -$37.1K | 1.34% | 14 |
|
2024
Q1 | $1.91M | Sell |
13,909
-358
| -3% | -$49.1K | 1.41% | 15 |
|
2023
Q4 | $1.94M | Buy |
+14,267
| New | +$1.94M | 1.53% | 16 |
|